News Home

Is Spectrum Pharmaceuticals, Inc. (SPPI) a Smart Choice in Biotechnology Monday?

Monday, December 06, 2021 10:08 AM | InvestorsObserver Analysts
Is Spectrum Pharmaceuticals, Inc. (SPPI) a Smart Choice in Biotechnology Monday?

Spectrum Pharmaceuticals, Inc. (SPPI) is around the middle of the Biotechnology industry according to InvestorsObserver. SPPI received an overall rating of 36, which means that it scores higher than 36 percent of all stocks. Spectrum Pharmaceuticals, Inc. also achieved a score of 44 in the Biotechnology industry, putting it above 44 percent of Biotechnology stocks. Biotechnology is ranked 89 out of the 148 industries.

Overall Score - 36
SPPI has an Overall Score of 36. Find out what this means to you and get the rest of the rankings on SPPI!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Spectrum Pharmaceuticals, Inc. Stock Today?

Spectrum Pharmaceuticals, Inc. (SPPI) stock is down -1.09% while the S&P 500 is up 0.6% as of 10:07 AM on Monday, Dec 6. SPPI is down -$0.01 from the previous closing price of $1.37 on volume of 1,402,797 shares. Over the past year the S&P 500 has risen 23.67% while SPPI is down -71.25%. SPPI lost -$1.06 per share the over the last 12 months. Click Here to get the full Stock Report for Spectrum Pharmaceuticals, Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App